[en] Facioscapulohumeral muscular dystrophy (FSHD), the most frequent muscular dystrophy, is an autosomal dominant disease. In most individuals with FSHD, symptoms are restricted to muscles of the face, arms, legs, and trunk. FSHD is genetically linked to contractions of the D4Z4 repeat array causing activation of several genes. One of these maps in the repeat itself and expresses the DUX4 (the double homeobox 4) transcription factor causing a gene deregulation cascade. In addition, analyses of the RNA or protein expression profiles in muscle have indicated deregulations in the oxidative stress response. Since oxidative stress affects peripheral muscle function, we investigated mitochondrial function and oxidative stress in skeletal muscle biopsies and blood samples from patients with FSHD and age-matched healthy controls, and evaluated their association with physical performances. We show that specifically, oxidative stress (lipid peroxidation and protein carbonylation), oxidative damage (lipofuscin accumulation), and antioxidant enzymes (catalase, copper-zinc-dependent superoxide dismutase, and glutathione reductase) were higher in FSHD than in control muscles. FSHD muscles also presented abnormal mitochondrial function (decreased cytochrome c oxidase activity and reduced ATP synthesis). In addition, the ratio between reduced (GSH) and oxidized glutathione (GSSG) was strongly decreased in all FSHD blood samples as a consequence of GSSG accumulation. Patients with FSHD also had reduced systemic antioxidative response molecules, such as low levels of zinc (a SOD cofactor), selenium (a GPx cofactor involved in the elimination of lipid peroxides), and vitamin C. Half of them had a low ratio of gamma/alpha tocopherol and higher ferritin concentrations. Both systemic oxidative stress and mitochondrial dysfunction were correlated with functional muscle impairment. Mitochondrial ATP production was significantly correlated with both quadriceps endurance (T(LimQ)) and maximal voluntary contraction (MVC(Q)) values (rho=0.79, P=0.003; rho=0.62, P=0.05, respectively). The plasma concentration of oxidized glutathione was negatively correlated with the T(LimQ), MVC(Q) values, and the 2-min walk distance (MWT) values (rho=-0.60, P=0.03; rho=-0.56, P=0.04; rho=-0.93, P<0.0001, respectively). Our data characterized oxidative stress in patients with FSHD and demonstrated a correlation with their peripheral skeletal muscle dysfunction. They suggest that antioxidants that might modulate or delay oxidative insult may be useful in maintaining FSHD muscle functions.
Disciplines :
Surgery
Author, co-author :
Turki, Ahmed
Hayot, Maurice
Carnac, Gilles
Pillard, Fabien
Passerieux, Emilie
Bommart, Sebastien
Raynaud de Mauverger, Eric
Hugon, Gerald
PINCEMAIL, Joël ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie cardio-vasculaire
D.B. Olsen, P. Gideon, T.D. Jeppesen, and J. Vissing Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI J. Neurol. 253 2006 1437 1441
S. Pandya, W.M. King, and R. Tawil Facioscapulohumeral dystrophy Phys. Ther. 88 2008 105 113
R. Tawil, and S.M. Van Der Maarel Facioscapulohumeral muscular dystrophy Muscle Nerve 34 2006 1 15
M. Wohlgemuth, E.L. van der Kooi, R.G. van Kesteren, S.M. van der Maarel, and G.W. Padberg Ventilatory support in facioscapulohumeral muscular dystrophy Neurology 63 2004 176 178
P. Laforet, C. de Toma, B. Eymard, H.M. Becane, M. Jeanpierre, M. Fardeau, and D. Duboc Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy Neurology 51 1998 1454 1456
J.C. van Deutekom, C. Wijmenga, E.A. van Tienhoven, A.M. Gruter, J.E. Hewitt, G.W. Padberg, G.J. van Ommen, M.H. Hofker, and R.R. Frants FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit Hum. Mol. Genet 2 1993 2037 2042
J.H. Lee, K. Goto, C. Matsuda, and K. Arahata Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35 Muscle Nerve 2 1995 S6 13
J.E. Hewitt, R. Lyle, L.N. Clark, E.M. Valleley, T.J. Wright, C. Wijmenga, J.C. van Deutekom, F. Francis, P.T. Sharpe, and M. Hofker Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy Hum. Mol. Genet 3 1994 1287 1295
J. Gabriels, M.C. Beckers, H. Ding, A. De Vriese, S. Plaisance, S.M. van der Maarel, G.W. Padberg, R.R. Frants, J.E. Hewitt, D. Collen, and A. Belayew Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element Gene 236 1999 25 32
P. Arashiro, I. Eisenberg, A.T. Kho, A.M. Cerqueira, M. Canovas, H.C. Silva, R.C. Pavanello, S. Verjovski-Almeida, L.M. Kunkel, and M. Zatz Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers Proc. Natl. Acad. Sci. USA 106 2009 6220 6225
D. Gabellini, G. D'Antona, M. Moggio, A. Prelle, C. Zecca, R. Adami, B. Angeletti, P. Ciscato, M.A. Pellegrino, R. Bottinelli, M.R. Green, and R. Tupler Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1 Nature 439 2006 973 977
G. Jiang, F. Yang, P.G. van Overveld, V. Vedanarayanan, S. van der Maarel, and M. Ehrlich Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q Hum. Mol. Genet 12 2003 2909 2921
R.J. Osborne, S. Welle, S.L. Venance, C.A. Thornton, and R. Tawil Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy Neurology 68 2007 569 577
S.T. Winokur, K. Barrett, J.H. Martin, J.R. Forrester, M. Simon, R. Tawil, S.A. Chung, P.S. Masny, and D.A. Figlewicz Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress Neuromuscul. Disord 13 2003 322 333
S.T. Winokur, Y.W. Chen, P.S. Masny, J.H. Martin, J.T. Ehmsen, S.J. Tapscott, S.M. van der Maarel, Y. Hayashi, and K.M. Flanigan Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation Hum. Mol. Genet 12 2003 2895 2907
R. Tawil Facioscapulohumeral muscular dystrophy Neurotherapeutics 5 2008 601 606
W. Zeng, J.C. de Greef, Y.Y. Chen, R. Chien, X. Kong, H.C. Gregson, S.T. Winokur, A. Pyle, K.D. Robertson, J.A. Schmiesing, V.E. Kimonis, J. Balog, R.R. Frants, A.R. Ball Jr, L.F. Lock, P.J. Donovan, S.M. van der Maarel, and K. Yokomori Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD) PLoS Genet. 2009 be1000559
P.W. Lunt, P.E. Jardine, M. Koch, J. Maynard, M. Osborn, M. Williams, P.S. Harper, and M. Upadhyaya Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy Muscle Nerve 2 1995 S103 109
C. Wijmenga, L. Deaven, and R.R. Frants Dinucleotide repeat polymorphism adjacent to the ANT1 gene on 4q35 Nucleic Acids Res. 20 1992 1161
K. Li, C.K. Warner, J.A. Hodge, S. Minoshima, J. Kudoh, R. Fukuyama, M. Maekawa, Y. Shimizu, N. Shimizu, and D.C. Wallace A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed J. Biol. Chem. 264 1989 13998 14004
J.C. van Deutekom, R.J. Lemmers, P.K. Grewal, M. van Geel, S. Romberg, H.G. Dauwerse, T.J. Wright, G.W. Padberg, M.H. Hofker, J.E. Hewitt, and R.R. Frants Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35 Hum. Mol. Genet 5 1996 581 590
T. Rijkers, G. Deidda, S. van Koningsbruggen, M. van Geel, R.J. Lemmers, J.C. van Deutekom, D. Figlewicz, J.E. Hewitt, G.W. Padberg, R.R. Frants, and S.M. van der Maarel FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients J. Med. Genet. 41 2004 826 836
R.J. Lemmers, P.J. van der Vliet, R. Klooster, S. Sacconi, P. Camano, J.G. Dauwerse, L. Snider, K.R. Straasheijm, G.J. van Ommen, G.W. Padberg, D.G. Miller, S.J. Tapscott, R. Tawil, R.R. Frants, and S.M. van der Maarel A unifying genetic model for facioscapulohumeral muscular dystrophy Science 329 2010 1650 1653
D. Bosnakovski, Z. Xu, E.J. Gang, C.L. Galindo, M. Liu, T. Simsek, H.R. Garner, S. Agha-Mohammadi, A. Tassin, F. Coppee, A. Belayew, R.R. Perlingeiro, and M. Kyba An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies EMBO J 27 2008 2766 2779
V. Kowaljow, A. Marcowycz, E. Ansseau, C.B. Conde, S. Sauvage, C. Matteotti, C. Arias, E.D. Corona, N.G. Nunez, O. Leo, R. Wattiez, D. Figlewicz, D. Laoudj-Chenivesse, A. Belayew, F. Coppee, and A.L. Rosa The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein Neuromuscul. Disord 17 2007 611 623
M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi, H. Qian, S. Sauvage, C. Matteotti, A.M. van Acker, O. Leo, D. Figlewicz, M. Barro, D. Laoudj-Chenivesse, A. Belayew, F. Coppee, and Y.W. Chen DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 Proc. Natl. Acad. Sci. USA 104 2007 18157 18162
C. Vanderplanck, E. Ansseau, S. Charron, N. Stricwant, A. Tassin, D. Laoudj-Chenivesse, S.D. Wilton, F. Coppee, and A. Belayew The FSHD atrophic myotube phenotype is caused by DUX4 expression PLoS One 6 2011 e26820
L.M. Wallace, S.E. Garwick, W. Mei, A. Belayew, F. Coppee, K.J. Ladner, D. Guttridge, J. Yang, and S.Q. Harper DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo Ann. Neurol. 2010
V. Macaione, M. Aguennouz, C. Rodolico, A. Mazzeo, A. Patti, E. Cannistraci, L. Colantone, R.M. Di Giorgio, G. De Luca, and G. Vita RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy Acta Neurol. Scand. 115 2007 115 121
D. Laoudj-Chenivesse, G. Carnac, C. Bisbal, G. Hugon, S. Bouillot, C. Desnuelle, Y. Vassetzky, and A. Fernandez Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle J. Mol. Med. 83 2005 216 224
B. Celegato, D. Capitanio, M. Pescatori, C. Romualdi, B. Pacchioni, S. Cagnin, A. Vigano, L. Colantoni, S. Begum, E. Ricci, R. Wait, G. Lanfranchi, and C. Gelfi Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes Proteomics 6 2006 5303 5321
M. Barro, G. Carnac, S. Flavier, J. Mercier, Y. Vassetzky, and D. Laoudj-Chenivesse Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects J. Cell. Mol. Med. 14 2010 275 289
S. Cheli, S. Francois, B. Bodega, F. Ferrari, E. Tenedini, E. Roncaglia, S. Ferrari, E. Ginelli, and R. Meneveri Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns PLoS One 6 2011 e20966
P.J. Vignos Jr, G.E. Spencer Jr, and K.C. Archibald Management of progressive muscular dystrophy in childhood JAMA 184 1963 89 96
L.E. Voorrips, A.C. Ravelli, P.C. Dongelmans, P. Deurenberg, and W.A. Van Staveren A physical activity questionnaire for the elderly Med. Sci. Sports Exerc. 23 1991 974 979
L.F. Black, and R.E. Hyatt Maximal respiratory pressures: normal values and relationship to age and sex Am. Rev. Respir. Dis. 99 1969 696 702
C. Koechlin, A. Couillard, D. Simar, J.P. Cristol, H. Bellet, M. Hayot, and C. Prefaut Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 169 2004 1022 1027
A. Couillard, C. Koechlin, J.P. Cristol, A. Varray, and C. Prefaut Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients Eur. Respir. J. 20 2002 1123 1129
I. Serres, V. Gautier, A. Varray, and C. Prefaut Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients Chest 113 1998 900 905
D. Delample, F. Durand, A. Severac, M. Belghith, E. Mas, F. Michel, J.P. Cristol, M. Hayot, and C. Prefaut Implication of xanthine oxidase in muscle oxidative stress in COPD patients Free Radic. Res. 42 2008 807 814
D. Brooks, J. Parsons, J.P. Hunter, M. Devlin, and J. Walker The 2-minute walk test as a measure of functional improvement in persons with lower limb amputation Arch. Phys. Med. Rehabil. 82 2001 1478 1483
A.S. Leung, K.K. Chan, K. Sykes, and K.S. Chan Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of COPD patients Chest 130 2006 119 125
C. Thomas, S. Perrey, K. Lambert, G. Hugon, D. Mornet, and J. Mercier Monocarboxylate transporters, blood lactate removal after supramaximal exercise, and fatigue indexes in humans J. Appl. Physiol. 98 2005 804 809
B. Roels, C. Thomas, D.J. Bentley, J. Mercier, M. Hayot, and G. Millet Effects of intermittent hypoxic training on amino and fatty acid oxidative combustion in human permeabilized muscle fibers J. Appl. Physiol. 102 2007 79 86
J. Haleng, J. Pincemail, J.O. Defraigne, C. Charlier, and J.P. Chapelle [Oxidative stress] Rev. Med. Liege 62 2007 628 638
J. Pincemail, C. Le Goff, C. Charlier, P. Gillion, J.P. Cheramy-Bien, E. Van Honacker, J.P. Chapelle, and J.O. Defraigne Evaluation biologique du stress oxydant: application en routine clinique Nutr. Endocrinol 2009 16 31
J. Pincemail, S. Vanbelle, U. Gaspard, G. Collette, J. Haleng, J.P. Cheramy-Bien, C. Charlier, J.P. Chapelle, D. Giet, A. Albert, R. Limet, and J.O. Defraigne Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium Hum. Reprod. 22 2007 2335 2343
H. Tohma, A.R. Hepworth, T. Shavlakadze, M.D. Grounds, and P.G. Arthur Quantification of ceroid and lipofuscin in skeletal muscle J. Histochem. Cytochem. 59 2011 769 779
R.J. Ragusa, C.K. Chow, and J.D. Porter Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy Neuromuscul. Disord 7 1997 379 386
M.C. Rodriguez, and M.A. Tarnopolsky Patients with dystrophinopathy show evidence of increased oxidative stress Free Radic. Biol. Med. 34 2003 1217 1220
Y. Nakae, P.J. Stoward, T. Kashiyama, M. Shono, A. Akagi, T. Matsuzaki, and I. Nonaka Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice J. Mol. Histol. 35 2004 489 499
R.J. Keller, N.C. Halmes, J.A. Hinson, and N.R. Pumford Immunochemical detection of oxidized proteins Chem. Res. Toxicol. 6 1993 430 433
E.R. Stadtman, and R.L. Levine Protein oxidation Ann. N. Y. Acad. Sci. 899 2000 191 208
M. Vendelin, N. Beraud, K. Guerrero, T. Andrienko, A.V. Kuznetsov, J. Olivares, L. Kay, and V.A. Saks Mitochondrial regular arrangement in muscle cells: a crystal-like pattern Am. J. Physiol. Cell Physiol 288 2005 C757 C767
P. Sirvent, S. Bordenave, M. Vermaelen, B. Roels, G. Vassort, J. Mercier, E. Raynaud, and A. Lacampagne Simvastatin induces impairment in skeletal muscle while heart is protected Biochem. Biophys. Res. Commun. 338 2005 1426 1434
A.V. Kuznetsov, V. Veksler, F.N. Gellerich, V. Saks, R. Margreiter, and W.S. Kunz Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells Nat. Protoc. 3 2008 965 976
R. Ouhabi, M. Boue-Grabot, J.P. Mazat, and A.T.P. Mitochondrial synthesis in permeabilized cells: assessment of the ATP/O values in situ Anal. Biochem. 263 1998 169 175
S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana, and C.R. Oliveira Cytochrome c oxidase is decreased in Alzheimer's disease platelets Neurobiol. Aging 25 2004 105 110
M.F. Beal Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis Ann. Neurol. 44 1998 S110 114
S. van Koningsbruggen, R.W. Dirks, A.M. Mommaas, J.J. Onderwater, G. Deidda, G.W. Padberg, R.R. Frants, and S.M. van der Maarel FRG1P is localised in the nucleolus, Cajal bodies, and speckles J. Med. Genet. 41 2004 e46
S. van Koningsbruggen, K.R. Straasheijm, E. Sterrenburg, N. de Graaf, H.G. Dauwerse, R.R. Frants, and S.M. van der Maarel FRG1P-mediated aggregation of proteins involved in pre-mRNA processing Chromosoma 116 2007 53 64
M.L. Hanel, R.D. Wuebbles, and P.L. Jones Muscular dystrophy candidate gene FRG1 is critical for muscle development Dev. Dyn. 238 2009 1502 1512
R.D. Wuebbles, M.L. Hanel, and P.L.F.S.H.D. Jones region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy Dis. Model Mech 2 2009 267 274
M. Richards, F. Coppee, N. Thomas, A. Belayew, and M. Upadhyaya Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum. Genet. 131 2012 325 340
L.N. Geng, Z. Yao, L. Snider, A.P. Fong, J.N. Cech, J.M. Young, S.M. van der Maarel, W.L. Ruzzo, R.C. Gentleman, R. Tawil, and S.J. Tapscott DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy Dev. Cell 22 2012 38 51
L. Sun, O.H. Franco, F.B. Hu, L. Cai, Z. Yu, H. Li, X. Ye, Q. Qi, J. Wang, A. Pan, Y. Liu, and X. Lin Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese J. Clin. Endocrinol. Metab. 93 2008 4690 4696
S. Pietri, M. Culcasi, L. Stella, and P.J. Cozzone Ascorbyl free radical as a reliable indicator of free-radical-mediated myocardial ischemic and post-ischemic injury. A real-time continuous-flow ESR study Eur. J. Biochem 193 1990 845 854
S. Pietri, J.R. Seguin, P.D. d'Arbigny, and M. Culcasi Ascorbyl free radical: a noninvasive marker of oxidative stress in human open-heart surgery Free Radic. Biol. Med. 16 1994 523 528
B.H. Rovin, J.A. Dickerson, L.C. Tan, and J. Fassler Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status Cytokine 9 1997 178 186
L.R. Pena, D.B. Hill, and C.J. McClain Treatment with glutathione precursor decreases cytokine activity JPEN J. Parenter. Enteral Nutr 23 1999 1 6
J.J. Haddad, B. Safieh-Garabedian, N.E. Saade, S.A. Kanaan, and S.C. Land Chemioxyexcitation (delta pO2/ROS)-dependent release of IL-1 beta, IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium Cytokine 13 2001 138 147
L.W. Chang, W.S. Lo, and P. Lin Trans, trans-2,4-decadienal, a product found in cooking oil fumes, induces cell proliferation and cytokine production due to reactive oxygen species in human bronchial epithelial cells Toxicol. Sci 87 2005 337 343
L.A. Callahan, Z.W. She, and T.M. Nosek Superoxide, hydroxyl radical, and hydrogen peroxide effects on single-diaphragm fiber contractile apparatus J. Appl. Physiol. 90 2001 45 54
T. Spencer, and G.S. Posterino Sequential effects of GSNO and H 2O2 on the Ca2 sensitivity of the contractile apparatus of fast- and slow-twitch skeletal muscle fibers from the rat Am. J. Physiol. Cell Physiol 296 2009 C1015 C1023
J.N. Edwards, W.A. Macdonald, C. van der Poel, and D.G. Stephenson O2(-) production at 37 degrees C plays a critical role in depressing tetanic force of isolated rat and mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 293 2007 C650 C660
V.A. Saks, V.I. Veksler, A.V. Kuznetsov, L. Kay, P. Sikk, T. Tiivel, L. Tranqui, J. Olivares, K. Winkler, F. Wiedemann, and W.S. Kunz Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo Mol. Cell. Biochem. 184 1998 81 100
D.R. Wood, J.S. Nye, N.J. Lamb, A. Fernandez, and M. Kitzmann Intracellular retention of caveolin 1 in presenilin-deficient cells J. Biol. Chem. 280 2005 6663 6668
M. Royuela, D. Chazalette, G. Hugon, R. Paniagua, V. Guerlavais, J.A. Fehrentz, J. Martinez, J.P. Labbe, F. Rivier, and D. Mornet Formation of multiple complexes between beta-dystroglycan and dystrophin family products J. Muscle Res. Cell Motil. 24 2003 387 397
H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
C. Koechlin, F. Maltais, D. Saey, A. Michaud, P. LeBlanc, M. Hayot, and C. Prefaut Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease Thorax 60 2005 834 841
S.T. Omaye, J.D. Turnbull, and H.E. Sauberlich Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids Methods Enzymol. 62 1979 3 11
B. Zhao, S.Y. Tham, J. Lu, M.H. Lai, L.K. Lee, and S.M. Moochhala Simultaneous determination of vitamins C, E and beta-carotene in human plasma by high-performance liquid chromatography with photodiode-array detection J. Pharm. Pharm. Sci. 7 2004 200 204
D.I. Thurnham, J.A. Davies, B.J. Crump, R.D. Situnayake, and M. Davis The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status Ann. Clin. Biochem. 23 Pt 5 1986 514 520
K.F. Gey Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer Biofactors 7 1998 113 174
H. Baker, G.J. Handelman, S. Short, L.J. Machlin, H.N. Bhagavan, E.A. Dratz, and O. Frank Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects Am. J. Clin. Nutr. 43 1986 382 387
S. Sturup, R.B. Hayes, and U. Peters Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS Anal. Bioanal. Chem 381 2005 686 694
D.R. Duling Simulation of multiple isotropic spin-trap EPR spectra J. Magn. Reson. B 104 1994 105 110